Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru
MERCURY
Development and Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among Men Who Have Sex With Men (MSM) in Perú ("PROJECT MERCURY")
3 other identifiers
interventional
161
1 country
2
Brief Summary
This study is testing a new program designed to improve access to HIV testing and help connect people with available treatment or prevention services, based on their test result. The version of the program being tested in this study was designed for men who have sex with men (MSM) in Lima, Peru. The program has two main parts: 1) offering HIV testing at venues where people go for sex (called "sex-on-premises venues" or SOPVs), and 2) a text messaging app that shares useful information about HIV treatment/prevention; users can also message back to get support from a healthcare worker. Before doing this study, the researchers worked with community members and healthcare providers in the area to make sure that the HIV testing approach and mobile app were designed in a way that would be engaging and meet their needs. Every Thursday, Friday, and Saturday night during recruitment, the researchers will go to SOPVs popular among the MSM community in Lima and invite people to take an HIV test. On each recruitment date, they will offer one of the following HIV testing options:
- The number and percentage of people who accept the program when offered
- The number and percentage of participants who continue to engage with the mobile app after 3 months The study will also measure:
- overall satisfaction with the app (based on a questionnaire sent at 3 months)
- the number and percentage of participants who completed any form of HIV testing after 3 months
- the number and percentage of participants who started HIV treatment (out of those with a positive HIV test)
- the number and percentage of participants who started HIV pre-exposure prophylaxis, or "PrEP" (out of those with a negative HIV test) All follow-up will be done remotely. Participants will have the app for 3 months. After 3 months, they will get a follow-up questionnaire asking about their experiences with the program. The researchers will keep tracking results related to the HIV treatment/prevention services that people receive for up to 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2025
CompletedFirst Submitted
Initial submission to the registry
July 11, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedFebruary 13, 2026
January 1, 2026
6 months
July 11, 2025
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intervention Uptake
The proportion of individuals who accept the intervention and enroll in the study among those who are approached and offered the intervention at the recruitment venue.
30 minutes
Continued Engagement
The proportion of participants who remain engaged with the mHealth component of the intervention over time, as indicated by having either 1) sent at least one text message reply (either responding directly to a programmed message or spontaneously messaging the provider team) or 2) logged into the WelTel online portal (or otherwise accessed the application content) within the previous 15 days.
3 months
Secondary Outcomes (2)
HIV test completion
3 months
User satisfaction
3 months
Other Outcomes (7)
Linkage to HIV care
3 months, 6 months
ART initiation
3 months, 6 months
Linkage to HIV prevention
3 months, 6 months
- +4 more other outcomes
Study Arms (4)
Group 1 - Rapid Test
ACTIVE COMPARATORParticipants will receive a rapid HIV test on-site at the time of enrollment.
Group 2 - HIV Self-Test
ACTIVE COMPARATORParticipants will be given an HIV self-test kit that they may use at the time and place of their choosing.
Group 3 - Coupon
ACTIVE COMPARATORParticipants will be given a coupon redeemable for a free future HIV test at a participating health center.
Group 4 - "Choice"
ACTIVE COMPARATORParticipants will be offered their choice of any one of the three HIV testing formats (rapid test, self-test, referral coupon).
Interventions
The intervention includes two core components: 1. HIV testing offered at sex-on-premises-venues \[SOPVs\]; 2. mHealth-supported linkage to treatment/prevention services (enrollment in a two-way text messaging application adapted from the WelTel platform). In this trial, the specific format of HIV testing offered will differ according to intervention arm.
Eligibility Criteria
You may qualify if:
- age ≥ 18 years
- identifies as gay, bisexual, or other man who has sex with men (MSM)
- attendance at the designated recruitment venue (SOPV) and is willing to receive the form HIV testing (i.e., intervention arm) offered on that recruitment date
- has a mobile phone device and service capable of two-way SMS text messaging via the WelTel platform and is willing to send/receive text messages using their primary mobile phone number
- able to read and write
You may not qualify if:
- self-reports having a previous HIV diagnosis
- cognitively or psychologically unable to participate in HIV testing (e.g. visibly intoxicated or self-reports being intoxicated)
- unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Epicentro, Perucollaborator
- Fred Hutchinson Cancer Centerlead
- Asociación Civil Via Libre, Perucollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (2)
Epicentro
Lima, Lima Province, Peru
Via Libre
Lima, Lima Province, Peru
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander J Lankowski, MD
Fred Hutchinson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate in VIDD
Study Record Dates
First Submitted
July 11, 2025
First Posted
July 20, 2025
Study Start
June 12, 2025
Primary Completion
December 13, 2025
Study Completion
March 31, 2026
Last Updated
February 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
Deidentified data (baseline and follow-up surveys; primary, secondary, and exploratory outcomes) may be shared upon reasonable request by contacting the Principal Investigator.